Small Company Champion & Lemming Investors Research and Newsletter Updates

Thursday, 15 April 2021

Open Orphan - Potential demerger of certain non-core assets


 

Shares Open Orphan Plc (AIM: ORPH), took a tumble in early trading (recovering almost all the lost ground at the end of trading) likely due to some confusion over the T&Cs of being handed what is essentially free money. The specialist pharmaceutical services clinical research organisation (CRO) and a world leader in vaccine and antiviral testing using human challenge clinical trials, announces that it is at an advanced stage in planning for a possible spin-out of certain non-core Development IP Assets. However, the use of the word lock-in appears to have spooked some of the lemming natives amongst us. 







Sunday, 11 April 2021

Open Orphan - Launch of Disease in Motion platform Launch

 



 

Open Orphan Plc (ORPH), a rapidly growing speciality pharmaceutical services clinical research organisation (CRO) and world leader in vaccine and antiviral testing using human challenge clinical trials, announces that hVIVO, a subsidiary of Open Orphan, has officially launched its Disease in Motion® platform. This unique data-focused platform includes clinical, immunological, virological and digital (wearable) biomarkers. The Disease in Motion platform has multiple infectious disease applications that apply to a wide variety of end-users, including big tech, wearables, pharma and biotech companies.

 



Ramsdens Holdings - Dissapointing Trading Due to Covid-19

 


Ramsdens Holdings Plc (RFX) the diversified financial services provider and retailer, announces a pre-close trading update for the six months ended 31 March 2021. Announced it has been affected negatively by fewer transactions from its lucrative jewellery retail trading and foreign currency, thus the company expects a "small loss" for its first half, due to Covid-19 restrictions.

It did flag these as likely issues. However, the focus was always on post-Covid-19 and therefore the smart money would be accumulating ahead of normality because the company is in a solid position with no financial issues concerning its survival. 



Spectra Systems - Receives notice of allowance from US Patent & Trademark Office

 


Spectra Systems (SPSY) Receives notice of allowance from the US Patent & Trademark Office for banknote disinfecting technology and expects a patent within six weeks. Technology can disinfect 5 million banknotes in less than two hours by using nitrogen to create an oxygen-free atmosphere, along with heat, to deactivate SARS-2. Other applications have been filed in other regions across the world.

Chief Executive Nabil Lawandy says, "Central banks and casinos that exchange cash with the public may conclude that a proactive approach rather than denial is the logical approach to maintaining the use of cash worldwide." 

Original Zulu report 

POPULAR COMPANIES